All > Post Traumatic Stress Disorder > Washington

JZP150 for Post Traumatic Stress Disorder

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Post Traumatic Stress DisorderJZP150 - Drug
Eligibility
18 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether JZP150 is a safe and effective treatment for adults with PTSD.

Eligible Conditions
  • Post Traumatic Stress Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Attention Control Training
1
Lu AG06466
1
NYX-783

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline to Week 12

Baseline to Week 12
Mean Change from Baseline to Week 12 in Clinical Global Impression of Severity (CGI-S)
Mean Change from Baseline to Week 12 in Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5) Total Symptom Severity Score
Mean Change from Baseline to Week 12 in Patient Global Impression of Severity (PGI-S)

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Attention Control Training
1
Lu AG06466
2
NYX-783

Trial Design

3 Treatment Groups

JZP150 0.3 mg
1 of 3
JZP150 4.0 mg
1 of 3
Placebo
1 of 3

Experimental Treatment

Non-Treatment Group

270 Total Participants · 3 Treatment Groups

Primary Treatment: JZP150 · Has Placebo Group · Phase 2

JZP150 0.3 mg
Drug
Experimental Group · 1 Intervention: JZP150 · Intervention Types: Drug
JZP150 4.0 mg
Drug
Experimental Group · 1 Intervention: JZP150 · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to week 12

Who is running the clinical trial?

Jazz PharmaceuticalsLead Sponsor
218 Previous Clinical Trials
29,999 Total Patients Enrolled

Eligibility Criteria

Age 18 - 70 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
People who want to participate in the study must be outpatients who have been diagnosed with post-traumatic stress disorder (PTSD) according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)

Who else is applying?

What state do they live in?
Texas53.8%
California15.4%
Ohio7.7%
Other23.1%
How old are they?
18 - 6590.0%
65+10.0%
What site did they apply to?
Austin Clinical Trial Partners14.3%
Clinical Trials of Texas28.6%
Altea Research14.3%
Other42.9%
What portion of applicants met pre-screening criteria?
Met criteria66.7%
Did not meet criteria33.3%

How responsive is this trial?

Most responsive sites:
  1. EZY Medical Research Co: < 48 hours
Average response time
  • < 2 Days
Typically responds via
Email100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top